Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of MEF2A mRNA | increases expression | 16631469
|
D001374 |
Azacitidine |
Azacitidine affects the expression of MEF2A protein | affects expression | 19002953
|
D001374 |
Azacitidine |
Azacitidine results in increased expression of MEF2A | increases expression | 12094073
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MEF2A mRNA | decreases expression | 19150397 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of MEF2A mRNA | increases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of MEF2A mRNA | decreases expression | 18042831
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of MEF2A mRNA | increases expression | 16001973
|
D004958 |
Estradiol |
Estradiol affects the expression of MEF2A mRNA | affects expression | 15598610
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of MEF2A mRNA | increases expression | 18955075 15674843
|
C041786 |
palm oil |
palm oil results in decreased expression of MEF2A mRNA | decreases expression | 18042831
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of MEF2A mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of MEF2A mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MEF2A mRNA | increases expression | 20106945
|
C025643 |
vinclozolin |
vinclozolin affects the expression of MEF2A mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.68 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 11752688 15322242 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.56 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.56 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
11.78 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
11.78 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.55 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.70 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.99 | 15238619 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.73 | 10378619 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.28 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.83 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.58 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.88 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.99 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.99 | 18234424 16096432 15567936 15692762 16935488 15136595 11325840 18695136 15994142 15939500 16115903 19526202 17369602 16264153 17426702 16826403 15993339 18628466 15668708 16322301 18382427 16595493 17983394 15634643 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.99 | 12948864 16675129 17289903 17018787 18497071 17261762 19861407 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.99 | 15572757 17595753 16912660 17440819 15758505 16837676 17893378 17952589 15775269 17242785 17049068 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.99 | 17049068 19115204 18997820 18351453 18984771 19189210 20005174 19221464 18629630 16202921 17242785 20135344 19487384 15668708 19288272 18815881 19066611 11161223 20859285 15565566 18425577 16873071 21138602 19189212 18821012 19084267 19289846 17893378 16273361 19142967 17261762 18855134 20065188 19011961 19103187 20544844 19244106 19200415 19410462 17440819 19155303 21152245 19059307 20390343 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.99 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.28 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
5.11 | 10378619 17687719 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.94 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.61 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.70 | 16023760 18059187 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.70 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.70 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.19 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.65 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.76 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.76 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.58 | 17007740 18627295 17382496 17924179 15811867 16269455 16612575 17329180 16952015 17351982 16278810 15505089 16242529 15476868 16364871 16731534 15792986 17131338 16455267 17974986 17928571 16109756 16651473 17308081 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.97 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.50 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.46 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.46 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.46 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.97 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 15668235 8697196 12621046 15340226 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.72 | 15800139 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.93 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.93 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
OMIM:608320 |
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1 |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.44 | 14966744 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.47 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.23 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
15.45 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
15.45 | 15920148 17308373 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
15.45 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.94 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.94 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.31 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.31 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.51 | 18367378 |
MESH:D004487 |
Edema |
|
Mustard Gas |
12.02 | 11402378 9260866 11428631 11428647 |
MESH:D004487 |
Edema |
|
Raloxifene |
12.02 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.02 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.56 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.56 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.78 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.78 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
12.78 | 19155303 20544844 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.29 | 18037988 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.28 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.09 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.50 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
19.50 | 17967931 18296743 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
19.50 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.50 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.28 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.64 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.84 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.84 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.35 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
15.35 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.35 | 20067830 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.05 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.43 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.40 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.58 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
8.03 | 12587719 16879835 16330681 16495754 16144979 16244372 14766674 18006777 16707910 17875725 17888722 16244371 18674790 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
8.03 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.39 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.98 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.48 | 15147373 18501091 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.89 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.67 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.70 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.75 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.75 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.75 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.09 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
12.31 | 20412841 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
12.31 | 11428647 9357497 11428620 16001271 8975870 11402378 9260866 17524151 11428631 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
12.31 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
12.31 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.54 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.54 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.35 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
10.35 | 16775033 15369732 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.35 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.23 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.78 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.78 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.78 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.58 | 16973256 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
3.73 | 19148494 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.29 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.70 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
3.01 | 17596541 18720364 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.28 | 19299654 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.85 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.21 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.92 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
5.03 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.03 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
5.03 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.03 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.49 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.49 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.07 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.07 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
3.50 | 18702808 18161513 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
6.71 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.71 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
6.71 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.71 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.71 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.52 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.86 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.67 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.88 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
10.29 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.29 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
10.29 | 19196723 11731420 16827153 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
13.10 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
13.10 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.45 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.45 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.30 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.09 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.58 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.69 | 15863610 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.22 | 19299654 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.91 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
7.92 | 19549372 18443271 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
7.92 | 16497877 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
4.05 | 19805378 17596541 18720364 17611569 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.98 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.34 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.69 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.97 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.97 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.54 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.13 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.87 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.54 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.54 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.78 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.78 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.30 | 15555623 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
4.06 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.30 | 19632207 21332399 18674790 20518802 11836018 16723640 17217161 20132043 18457598 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.44 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.31 | 17893378 15579764 17823083 15758505 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.18 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.24 | 19401270 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.29 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.29 | 17638057 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.88 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.88 | 11222880 11399792 11118676 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.88 | 19015723 18220299 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.05 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
1.88 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.88 | 16868541 16888761 18437689 15749863 15897917 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.88 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.88 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.05 | 18629315 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
4.21 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.95 | 17720292 17620002 17266442 10334151 17894541 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.69 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.33 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.06 | 17710206 15625365 17203757 18313854 16767912 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.34 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.91 | 17846226 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.73 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.81 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.81 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.67 | 16767912 15625365 17203757 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.43 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.15 | 19457130 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.89 | 16837676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.43 | 17909728 16010429 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
14.17 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
14.17 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.60 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.60 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.60 | 16712894 8653321 17572228 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.34 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.33 | 17334414 17638931 17678736 16364871 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.69 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.81 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |